We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » CorMedix Draws Complete Response Letter for Catheter-Lock Solution
CorMedix Draws Complete Response Letter for Catheter-Lock Solution
CorMedix has received a Complete Response Letter (CRL) from the FDA regarding a New Drug Application (NDA) for its catheter-lock solution, DefenCath (taurolidine/heparin).